Pure Bioscience, Inc. (PURE) — DEF 14A Filings
All DEF 14A filings from Pure Bioscience, Inc.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
PURE Bioscience Seeks 25% Stock Authorization Hike at 2026 Annual Meeting
— Dec 30, 2025 Risk: medium
PURE Bioscience, Inc. is holding its 2026 Annual Meeting of Stockholders on February 17, 2026, where key proposals include the election of seven directors, the -
Pure Bioscience Files Definitive Proxy Statement
— Dec 12, 2024 Risk: low
Pure Bioscience, Inc. filed a Definitive Proxy Statement (DEF 14A) on December 12, 2024. This filing is related to the company's proxy materials, which are typi -
PURE Bioscience, Inc. Announces 2024 Annual Meeting of Stockholders
— Jan 10, 2024 Risk: low
PURE BIOSCIENCE, INC. (PURE) filed a Proxy Statement (DEF 14A) with the SEC on January 10, 2024. The 2024 Annual Meeting of Stockholders for PURE Bioscience, In
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX